AACR Cancer Progress Report 2024
What is Cancer Precision Medicine? Research has powered an explosion in our understanding of the biology of cancer genomics and is leading to tailored treatments for patients.
Read the Report
What is Cancer Precision Medicine? Research has powered an explosion in our understanding of the biology of cancer genomics and is leading to tailored treatments for patients.
Read the Report
Cancer is not a single disease, but rather a collection of diseases all characterized by the uncontrolled proliferation of cells.
Learn MoreDisparities in Cancer Screening: Racial and ethnic minority populations and medically underserved communities experience substantial disparities in receiving the recommended cancer screenings.
Read the ReportMore than 234,000 people living in the United States are expected to be diagnosed with lung cancer this year. Learn about prevention, screening, and treatment options for lung cancer.
Learn MoreFor patients with liver cancer, can immunotherapy given before surgery—neoadjuvant immunotherapy—shrink tumors so they are safer to remove?
Read the AACR BlogThe current issue of Leading Discoveries magazine features articles on AACR President Patricia M. LoRusso’s efforts to improve clinical trials, an AACR initiative on communicating science effectively, and much more.
Read Leading DiscoveriesWhether honoring a special person or a special day, a donation to the American Association for Cancer Research has a lasting impact.
Donate NowSubmit an abstract for the AACR Annual Meeting 2025 (April 25-30, Chicago).
Deadline: November 26
The AACR Cancer Progress Report 2024 highlights research-driven advances against the collection of often devastating diseases we call cancer.
Learn MoreThe AACR and its more than 58,000 members worldwide are advancing a scientifically bold agenda against the collection of diseases we call cancer.
Learn MoreDr. LoRusso, AACR President 2024-2025, explains that basic cancer research is essential to accelerating advances in cancer science and medicine.
Learn Morepercent decrease of the overall age-adjusted cancer death rate in the U.S. from 1991 to 2021
Learn Moretherapeutics were approved for new or expanded uses by the FDA from July 1, 2023, to June 30, 2024
Learn Moremillion cancer survivors in the U.S. are living with, through, and beyond their disease thanks to research
Learn MoreYour donation to the American Association for Cancer Research helps our more than 58,000 members worldwide drive progress against cancer.
Donate Now
